Friday, March 25, 2011

UPDATE: FDA approves Bristol-Meyers Squibb's new skin cancer drug, ipilimumab (Yervoy)


http://www.businessweek.com/news/2011-03-25/bristol-myers-squibb-wins-u-s-approval-for-melanoma-drug.html

1 comment:

  1. Just sold Apr $27 call options @ $0.35 for a 40% profit overnight. Has potential to go higher but don’t want to risk it as many traders are looking to sell on the news.

    Options were originally purchased @ $0.25 yesterday – see comments under post http://michaeljuan.blogspot.com/2011/03/bristol-meyer-squibb-bmy-first-in-class.html

    ReplyDelete